共 17 条
Establishing clinically significant outcome thresholds for the Single Assessment Numeric Evaluation 2 years following total shoulder arthroplasty
被引:27
|作者:
Cohn, Matthew R.
[1
]
Kunze, Kyle N.
[1
]
Polce, Evan M.
[1
]
Nemsick, Michael
[1
]
Garrigues, Grant E.
[1
]
Forsythe, Brian
[1
]
Nicholson, Gregory P.
[1
]
Cole, Brian J.
[1
]
Verma, Nikhil N.
[1
]
机构:
[1] Rush Univ, Midwest Orthoped Rush, Dept Orthoped, Div Sports Med & Shoulder, Chicago, IL 60612 USA
基金:
美国国家卫生研究院;
关键词:
Clinical outcomes;
Single Assessment Numeric Evaluation (SANE);
total shoulder arthroplasty;
minimal clinically important difference (MCID);
substantial clinical benefit (SCB);
patient-reported outcome instrument validation;
D O I:
10.1016/j.jse.2020.07.011
中图分类号:
R826.8 [整形外科学];
R782.2 [口腔颌面部整形外科学];
R726.2 [小儿整形外科学];
R62 [整形外科学(修复外科学)];
学科分类号:
摘要:
Background: Single Assessment Numerical Evaluation (SANE) is a simple, time-efficient patient-reported outcome measure (PROM) used to assess postoperative shoulder function. Clinically significant outcome values and ability to correlate with longer legacy PROM scores at 2 years following shoulder arthroplasty are unknown. Methods: A retrospective analysis was performed using SANE, American Shoulder and Elbow Surgeons Standardized Shoulder Assessment Form (ASES), and Constant scores that were collected at a minimum 2-year follow-up. A total of 153 patients who underwent anatomic total shoulder arthroplasty (TSA) or reverse total shoulder arthroplasty (RTSA) were included. A distribution-based method was used to determine the minimal clinically important difference (MCID). An anchor-based method was used to determine substantial clinical benefit (SCB). The following anchor question was collected alongside the PROMs and graded on a 15-point Lik-ert-type scale to establish the SCB: "Since your surgery, has there been any change in the pain in your shoulder?'' Linear regression was used to assess correlations between PROMs. Results: SANE showed moderate correlation with ASES (R-2 = 0.493) and Constant (R-2 = 0.586) scores (P < .001). The MCID value was 14.9, and the SCB absolute value was 80.4 (area under the curve = 0.663) for SANE. Multivariate logistic regression demonstrated that patients undergoing RTSA were less likely to achieve SCB on all 3 outcome measures (P < .02). Conclusions: This study establishes concurrent construct validity for SANE and suggests that it is a valid metric to assess the MCID and SCB at 2 years following anatomic TSA and RTSA. SANE demonstrated moderate correlations with ASES and Constant scores. Patients undergoing RTSA demonstrated a lower propensity to achieve SCB at 2 years postoperatively compared with anatomic TSA. (C) 2020 Journal of Shoulder and Elbow Surgery Board of Trustees. All rights reserved.
引用
收藏
页码:E137 / E146
页数:10
相关论文